FDA’s Decision to Approve Aduhelm (aducanumab) for Alzheimer’s
Criticism of the FDA's decision to approve aducanumab for Alzheimer's disease.
The Delta Variant
The emergence of the delta variant of SARS-CoV-2, leading to more cases of COVID-19, is a reminder that we have not won this race against the pandemic yet.
The Causes of Bad Science Reporting
A discussion of reasons why science reporting so often gives the wrong impression about various scientific studies.
Integrative Neurology – More Bait and Switch
Integrative medicine is a marketing concept still rife with pseudoscience.
Nuance in Science Reporting
A study explores the pitfalls of following simple narratives in science reporting.
COVID Morbidity
The emerging burden of long COVID is significant, and needs to be considered when evaluating the risk vs benefit of pandemic measures.
The Causes of Vaccine Hesitancy
The vaccine hesitant are now the front lines of the battle to contain COVID.
Artificial Intelligence and Science-Based Medicine
AI tools in medicine are coming, and they can be powerful, but we have to manage how they are employed.
Spike Proteins, COVID-19, and Vaccines
A new study further elucidates the role of spike proteins in COVID-19.
The Science of Transgender Treatment
This is part I in what will be a short series of articles reviewing the science of transgender care and how it has been distorted by critics.